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Aim To determine whether therapeutic hypothermia (TH) 
improves survival and neurological outcomes in out-of-
hospital cardiac arrest (OHCA) survivors.
Methods This retrospective cohort study enrolled patients 
treated for OHCA with a return of spontaneous circulation 
admitted to the Cardiac Intensive Care Unit from October 
2000 until March 2019. Data were collected from medical 
archives. Propensity score matching was used. The prima-
ry endpoint was death during hospital stay and secondary 
endpoint was cerebral performance category (CPC) score 
at discharge.
Results Out of 152 patients included in the study, 58 
(38.7%) underwent TH treatment. After matching (which 
left 70 patients in the analysis), death during hospital stay 
occurred less often in TH group (28.6% vs 57.1%, P = 0.029), 
while the difference in CPC score was not significant. Cox 
proportional hazards model showed the predictors of 
death during hospital stay to be TH (hazard ratio [HR] 0.29, 
95% confidence interval [CI] 0.13-0.68, P = 0.004), initial 
Glasgow Coma Scale score of 3 (HR 7.55, 95% CI 1.44-39.63, 
P = 0.017), and heart failure (HR 2.35, 95% CI 1.02-5.34, 
P = 0.045). TH was not an independent predictor of CPC 
score. Mann-Whitney U test and linear regression model 
showed that TH was associated with higher gain in GCS.
Conclusion TH was associated with better survival and 
certain variables suggesting improved neurological out-
comes, suggesting that TH is a vital treatment option for 
comatose OHCA survivors.
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In the last two decades, therapeutic hypothermia (TH) has 
gained critical appraisal as a method of improving survival 
and neurological outcome in comatose cardiac arrest sur-
vivors (1). Some of the possible mechanisms behind the 
beneficial role of TH are decreasing brain metabolism, low-
ering of intracranial pressure, diminishing brain cell apop-
tosis and necrosis, decreasing the release of lactate and ex-
citotoxic compounds, reducing brain tissue inflammatory 
response and systemic inflammatory response syndrome, 
decreasing the production of free radicals, and limiting 
vascular and cell membrane permeability (2). Animal stud-
ies demonstrated a beneficial role of mild TH. For exam-
ple, Safar et al (3) showed better overall performance, final 
neurological deficit score, and total brain histopathologic 
damage scores in dogs treated with mild TH (34°C) after 
11 minutes of ventricular fibrillation as opposed to dogs 
that remained normothermic (37.5°C). Anecdotal experi-
ence from drowning accidents with circulatory arrest sug-
gested promising results in humans (4). After a random-
ized control trial Hypothermia after Cardiac Arrest (HACA) 
(5) and a pseudo-randomized trial by Bernard et al (6), TH 
was introduced into routine daily practice. However, sever-
al subsequent studies presented ambiguous results (7-13). 
It is currently widely debated whether improved outcomes 
are attributable to the TH alone or to the whole bundle 
of care, consisting of optimal mechanical ventilation, an-
algosedation, urgent coronary angiography and interven-
tion, infection control and treatment, and early rehabilita-
tion. We hypothesized that, in a real-life setting, TH indeed 
improved the outcomes and represented an essential part 
of critical care for comatose cardiac arrest survivors. To test 
this hypothesis, we analyzed the data from 20 years of ex-
perience in treating such patients in our Center. We com-
pared clinical, interventional, treatment, and outcome data 
of patients treated and not treated with TH.
PAtieNts AND MethoDs
study setting
The study was conducted at Sestre Milosrdnice Univer-
sity Hospital Center, a tertiary teaching center providing 
emergency care to an urban population of 350 000 inhab-
itants. Despite administrative territorial division, the hospi-
tal has a no-refusal policy for emergency patients, includ-
ing patients with no valid insurance policy. The center’s 
autonomous cardiac intensive care unit (ICU) provides 
mechanical ventilation, renal replacement therapy, me-
chanical circulatory support, and interventional cardiol-
ogy available 24/7.
Patients with out-of-hospital cardiac arrest (OHCA) are at-
tended by mobile emergency units with at least one phy-
sician per unit, who is able to provide both basic and ad-
vanced life support. After a call, the closest emergency unit 
is dispatched to the scene. The resuscitation is performed 
by a team trained in emergency medicine according to in-
ternational guidelines (14). On-field advance life support 
includes airway management with endotracheal tube or 
laryngeal mask in some cases, and recently more often with 
mechanical devices for chest compressions. Patients with 
return of spontaneous circulation (ROSC) are transferred 
to the emergency department (ED), where they undergo 
the initial work-up and consultation with an interventional 
cardiologist and intensivist. In patients with shockable ini-
tial rhythm, the decision whether to proceed with primary 
percutaneous coronary intervention (PCI) is made, often 
facilitated by urgent echocardiography. Patients with non-
shockable initial rhythm in the ED often undergo addi-
tional work-up, mostly consisting of brain and pulmonary 
artery computed tomography and aortography, with the 
purpose to exclude other potentially treatable or non-car-
diac causes of arrest.
Patient data
All patients treated for OHCA with ROSC who were admit-
ted to the cardiac ICU were eligible for enrollment. The in-
clusion criterion was cardiac arrest not witnessed by pro-
fessional health care providers (ie, outside primary health 
physician’s office, ED, and ambulance). Patients who de-
ceased in the ED were not considered for analysis. The an-
alyzed time period was from October 2000 until March 
2019. Patients were identified by reviewing medical his-
tories, admittance protocols, and physicians’ and nurses’ 
shift change documentation. The latter was available in 
handwritten form for every shift until 2015. Since 2015, 
these data have been entered electronically in a local da-
tabase. Every case with a diagnosis or remark suggesting 
cardiac arrest was reviewed. Upon case identification, all 
relevant clinical, work-up, interventional, treatment, and 
outcome details were collected from the medical ar-
chives. This included reviewing individual daily care, phys-
ical findings, vital parameters, medication lists, documen-
tation describing patient behavior (compliance, ability to 
talk, eat, perform simple tasks, or walk with or without as-
sistance), laboratory and radiographic work-up, and all 
interventional documentation, including video material. 
Overall, the data quality was acceptable. Out of 41 ana-
lyzed variables, 20 had no missing data and 16 had less 
than 5% missing data. The study was approved by 
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the Sestre Milosrdnice University Hospital Center Ethics 
Committee (EP-13659/19-4).
therapeutic hypothermia
TH was introduced into routine practice at our institution 
in 2014 and since then has been offered to every eligible 
patient. The treatment was performed as follows: patients 
with ROSC and GCS<8 were considered eligible regard-
less of the clinical scenario (all patients were considered 
candidates, even in the absence of written consent, which 
was later obtained from family members). Analgosedation 
was performed using midazolam and fentanyl (since 2017 
sufentanyl). All patients were intubated and mechanical-
ly ventilated. Core temperature was measured by esoph-
ageal temperature probe. TH was initiated in all patients 
within 6 hours from cardiac arrest. Rapid bolus (200-300 
mL/min) of 2000 mL of cold saline (4°C) was given using 
pressurized bags via a large bore catheter inserted in the 
femoral vein. This was immediately followed by the admin-
istration of frozen ice-packs on large body areas. Additional 
500 to 1000 mL of cold saline was allowed. The aim was to 
reach the target core temperature of 33°C (32-34°C) dur-
ing 24 hours. For shivering, the use of additional boluses or 
infusion rate increments of analgosedation was allowed. If 
shivering was untreatable, vecuronium was used. Rewarm-
ing was passive, targeted at 0.5°C per hour. Upon reaching 
normothermia, analgosedation was withdrawn.
All patients were treated according to contemporary 
guidelines (14-16). Invasive treatment, including primary 
PCI, was strongly advocated before and regardless of TH.
The primary endpoint was death during hospital stay. Neu-
rological disability was determined on arrival by Glasgow 
Coma Scale score (GCS), and at discharge by Cerebral Per-
formance Category (CPC) score, which was the secondary 
endpoint (CPC 1 or 2).
statistical analysis
Categorical variables are presented as counts and frequen-
cies, and the significance of differences between them 
was assessed with the χ2 or Fisher exact test. Continuous 
variables were tested for normality of distribution with the 
Kolmogorov-Smirnov test. They are presented as means 
and standard deviations (SD) or medians and interquartile 
ranges (IQR), and the significance of differences between 
them was assessed with the Mann-Whitney U test. Pro-
pensity score matching was performed with the fol-
lowing variables: age, GCS of 3 on admission, noradrena-
lin use, PCI, and treatment period since 2010. The missing 
values were excluded listwise, however, only GCS of 3 on 
admission had missing values (2.6%). Caliper was set to 
0.05. Matching was performed without replacement. All 
analyses were performed on matched population (univari-
ate analyses of unmatched population are presented in 
Table 1 for comparison). The quality of matching was as-
sessed by a logistic regression model with TH as depen-
dent variable and covariates of propensity score matching 
model. Cox proportional hazards model was used to deter-
mine the independent predictors of survival. Linear regres-
sion was used to determine the independent predictors 
of higher GCS gain. In both, Enter method was used. After 
matching, there were no missing data in variables includ-
ed in the multivariable analyses. Multicollinearity was as-
sessed by variance inflation factor (VIF). The mediation by 
admission year of TH’s effect on survival was assessed by 
using ordinary least squares and logistic regression path 
analysis modeling tool. Two-tailed significance tests were 
performed. P values lower than 0.05 were considered sig-
nificant. All statistical analyses were performed in SPSS for 
Windows, version 25 (IBM SPSS, Armonk, NY, USA).
Results
The study enrolled 152 patients. The admission trends are 
shown in Figure 1. The number of patients treated and 
not treated with TH according to the year of admission is 
shown in Figure 2. Out of all patients, 58 (38.7%) under-
went TH treatment. The patients’ characteristics, clinical, 
procedure, and treatment details are presented in Table 
1. After propensity score matching, 70 patients remained 
in the analysis (35 treated and 35 not treated with TH). In 
a logistic regression model created to test the quality of 
matching, pseudo R2 decreased from 0.467 before match-
ing to 0.013 after matching. Univariate analysis is presented 
in Table 1. Death during hospital stay occurred less often 
in the TH group (P = 0.029), while there was no difference 
in CPC score at discharge (P = 0.332). A Cox proportional 
hazards model with eight covariates (age, sex, history of 
diabetes, PCI, TH, use of noradrenalin, initial GCS of 3, and 
heart failure) significantly predicted death during hospi-
tal stay (χ2 = 35.9, P < 0.001). Survival curves with separate 
lines for TH and no TH group are presented in Figure 3. Sig-
nificant predictors of death during hospital stay were TH 
(hazard ratio [HR] 0.29, 95% confidence interval [CI] 0.13-
0.68, P = 0.004), initial GCS of 3 (HR 7.55, 95% CI 1.44-39.63, 
P = 0.017), and heart failure (HR 2.35, 95% CI 1.02-5.34, 
P = 0.045). After adding variables that were significantly dif-
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tABle 1. Clinical, interventional, treatment, and outcome data of patients treated and not treated with therapeutic hypothermia 
(whole study population and matched population by means of propensity score matching)*
use of therapeutic hypothermia, n (%)†
whole population matched population
no (n = 94) yes (n = 58) P no (n = 35) yes (n = 35) P
Female patients 18 (19.1) 18 (31.0) 0.117  7 (20.0) 11 (31.4) 0.413
Age 61.4 ± 14.6 61.9 ± 13.7 0.869 61.9 ± 14.2 63.1 ± 14.9 0.755
transferred patients‡  9 (9.6) 14 (24.1) 0.015  2 (5.7)  6 (17.1) 0.259
Diabetes mellitus 20 (21.7) 13 (22.8) 0.879  9 (25.7)  6 (17.1) 0.561
hypertension 54 (59.3) 31 (54.4) 0.553 23 (67.7) 18 (52.9) 0.212
Active smoking 29 (31.5) 16 (28.5) 0.705  7 (21.2)  8 (23.5) 0.822
Previous myocardial infarction 23 (24.7) 12 (21.4) 0.645  7 (20.6)  6 (18.2) 1.000
Previous CABG or PCi 16 (17.2)  8 (14.5) 0.672  5 (14.7)  4 (12.1) 1.000
Cardiac arrest at/outside the home 36/55 (39.6/60.4) 25/33 (43.1/56.9) 0.668 10/24 (29.4/70.6) 12/23 (34.3/65/7) 0.797
initial shockable rhythm 71 (82.6) 47 (81.0) 0.816 26 (86.7) 32 (91.4) 0.695
Witnessed arrest 52 (92.9) 51 (91.1) 0.728 16 (100.0) 32 (94.1) 1.000
Bystander CPR 27 (62.8) 27 (52.9) 0.336  7 (70.0) 18 (60.0) 0.715
time until eMs  5.5 (5-10)  8 (5-10) 0.511  8 (5-10)  7 (4-10) 0.727
time until RosC 29.1 ± 15.9 29.3 ± 23.9 0.684 32.0 ± 19.2 28.3 ± 26.0 0.489
use of mechanical chest compression devices  3 (3.1)  3 (5.2) 0.525  2 (5.7)  1 (2.9) 0.555
GCs on arrival  4 (3-15)  3 (3-3) <0.001  3 (3-15)  3 (3-4) 0.331
Airway on arrival (tube/iGel) 52/11 (55.9/11.8) 28/17 (50.0/30.4) 0.013 17/9 (48.6/25.7) 16/11 (48.5/33.3) 0.734
Recurrent arrest 39 (42.4) 25 (43.1) 0.932 18 (51.4) 12 (34.3) 0.227
Mechanical ventilation 55 (59.8) 58 (100.0) <0.001 25 (71.4) 35 (100.0) 0.001
etiology of arrest
CMP 14 (14.9) 20 (34.5) 0.019  5 (14.3) 11 (31.4) 0.155
other 14 (14.9)  6 (10.3)  5 (14.3)  6 (17.1)
ACS 66 (70.2) 32 (55.2) 25 (71.4) 18 (51.4)
urgent coronary angiography 38 (40.4) 45 (77.6) <0.001 18 (51.4) 27 (77.1) 0.045
urgent PCi 34 (36.2) 30 (51.7) 0.065 17 (48.6) 14 (40.0) 0.631
Analgosedation  4 (4.4) 58 (100.0) <0.001  1 (2.9) 35 (100.0) <0.001
Brain computed tomography 31 (33.7) 38 (66.7) <0.001 15 (44.1) 23 (67.6) 0.087
shock 26 (29.2) 27 (46.6) 0.032 15 (44.1) 10 (28.6) 0.216
use of any vasopressor 17 (18.1) 25 (43.1) 0.001 10 (28.6)  8 (22.9) 0.785
Noradrenalin  8 (8.5) 25 (43.1) <0.001  7 (20.0)  8 (22.9) 1.000
inotrope (dobutamine) 20 (21.7) 26 (44.8) 0.004 11 (31.4) 12 (34.3) 1.000
lVeF 45 (35-55) 45 (30-55) 0.707 50 (40-59) 48 (30-55) 0.215
heart failure 23 (27.1) 22 (37.9) 0.169  9 (25.7) 10 (28.6) 1.000
Pneumonia 23 (25.0) 29 (51.8) 0.001 10 (28.6) 18 (52.9) 0.051
sepsis  6 (6.5) 14 (25.0) 0.001  2 (5.7)  9 (26.5) 0.023
use of antibiotics 35 (38.5) 39 (69.6) <0.001 15 (44.1) 26 (76.5) 0.013
Culture requiring isolation  3 (3.3) 12 (21.4) <0.001  2 (5.9)  9 (26.5) 0.045
tracheostomy  4 (4.3) 12 (20.7) 0.001  3 (8.6)  9 (25.7) 0.110
Acute renal failure  5 (5.4)  6 (10.5) 0.240  1 (2.9)  3 (8.8) 0.356
Acute renal replacement therapy  0 (0.0)  5 (8.6) 0.004  0 (0.0)  2 (5.7) 0.493
length of hospital stay  7 (2-15) 12 (4-19.25) 0.019  5 (2-11) 15 (7-22) 0.001
Gain in GCs  0 (0-1)  2 (0-11) <0.001  0 (0-0)  3 (1-12) <0.001
CPC score 1 or 2 at discharge 47 (50.0) 22 (37.9) 0.147 12 (34.3) 17 (48.6) 0.332
intrahospital mortality 40 (42.6) 23 (39.7) 0.738 20 (57.1) 10 (28.6) 0.029
*ACs – acute coronary syndrome; CABG – coronary artery by-pass surgery; CMP – cardiomyopathy; CPR – cardio-pulmonary resuscitation; CPC – 
cerebral performance category; eMs – emergency medical service; GCs – Glasgow Coma scale score; lVeF – left ventricular ejection fraction; PCi – 
percutaneous coronary intervention; RosC – return of spontaneous circulation; sD – standard deviation.
†mean ± standard deviation for normal distribution, median (interquartile range) for non-normal distribution.
‡patients transferred from other regional hospitals.
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ferent between the TH and no TH group in univariate anal-
ysis (mechanical ventilation, urgent coronary angiography, 
use of antibiotics, sepsis) in the model, TH remained a sig-
nificant predictor of survival (Table 2). The highest record-
ed VIF for a single covariate in multiple computations was 
1.7. In mediation analysis, the indirect effect of TH on sur-
vival, as mediated by the year of admission, was not signifi-
cant (effect -0.102, bootstrap 95% CI -1.50-1.15). Equal Cox 
proportional hazards model significantly predicted CPC 
score at discharge (χ2 = 22.2, P = 0.005). Significant predic-
tors of CPC score at discharge were GCS of 3 on admission 
(HR 0.20, 95% CI 0.07-0.56, P = 0.002) and diabetes mellitus 
(HR 0.05, 95% CI 0.01-0.05, P = 0.008), but not the use of TH 
(HR 0.83, 95% CI 0.32-2.13, P = 0.696).
Neurological improvement was additionally expressed as 
the difference between the best and initial GCS score. The 
difference was significantly greater in patients treated with 
TH (P < 0.001). Linear regression was performed with vari-
ables used in the Cox proportional hazards models. Signifi-
cant predictors of higher gain in GCS were TH (odds ratio 
[OR] 4.9, 95% CI 2.8-6.7, P < 0.001), noradrenalin use (OR 
-2.3, 95% CI -5.8 to -0.4, P = 0.027), and age (OR -2.1, 95% CI 
-0.2 to -0.002, P = 0.043). The highest VIF was 1.4, for age. VIF 
for the use of TH was 1.0.
DisCussioN
This single-center observational cohort study showed that, 
after adjustments, TH was related to better survival and to 
certain variables suggesting improved neurological out-
come at hospital discharge. The study population was pre-
dominantly male, with a high prevalence of patients with 
active smoking status and diabetes. The majority of arrests 
occurred outside the home. Despite the preponderance 
of witnessed arrests (9 out of 10 cases), lay-person resus-
FiGuRe 1. the number of patients admitted to the cardiac 
intensive care unit after out-of-hospital cardiac arrest with 
return of spontaneous circulation per year.
FiGuRe 2. the number of patients (after propensity score 
matching) treated and not treated with therapeutic hypo-
thermia according to the year of admission.
tABle 2. Cox proportional hazards model assessing eight covariates in predicting survival. the model was significant with χ2 = 35.9 
and P < 0.001*
significance hazard ratio 95% confidence interval for hazard ratio
GCS = 3 on admission 0.017 7.548 1.438-39.628
Therapeutic hypothermia 0.004 0.295 0.128-0.681
Heart failure 0.045 2.336 1.020-5.349
Age 0.162 1.024 0.991-1.057
Diabetes mellitus 0.188 1.915 0.728-5.041
Female patients 0.319 0.623 0.245-1.580
Noradrenalin 0.520 1.368 0.535-3.448
Primary PCI 0.632 1.278 0.469-3.482
*GCs – Glasgow coma scale score; PCi – percutaneous coronary intervention.
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citation was performed in only 57.4% of patients. In a re-
cent study from Ireland, bystander CPR was performed in 
as many as 84% of witnessed arrests (17). Riva et al (18) re-
ported that the rate of OHCA with bystander CPR in Swe-
den increased from 30.8% in 2000-2005 to 68.2% in 2011-
2017. Such results indicate the need for further efforts in 
the education of lay-person CPR on the national level in 
Croatia. It is currently accepted that providing bystander 
CPR doubles the survival rate in OHCA patients.
Emergency service response in our patients was prompt 
(median 7 min [5-10 min] for total study group), with 63.0% 
of all patients reached under the recommended 8 minutes 
(19). Further response time reduction in urban areas is ex-
ceptionally demanding, but rewarding. Burger et al (20) 
reported a 5% reduction in the probability of survival per 
1-minute prolongation of emergency service response 
time. The mean time until ROSC of 29.2 ± 21.3 minutes in 
our study is similar to the times reported in other studies 
(21). Komatsu et al (22) reported this time to be 18.3 ± 15.1 
minutes in patients with good neurological outcome (CPC 
score 1 or 2), as opposed to 48.6 ± 17.9 minutes in patients 
with worse CPC score or death. The respective times in our 
study were reasonably comparable, 16.9 ± 10.9 minutes 
and 40.8 ± 22.4 minutes. The most common cause of arrest 
was acute coronary syndrome, a fact directly related to a 
high rate of urgent coronary angiography and PCI.
The comparison of patients treated and not treated with 
TH was hindered by the differences between the two 
groups. Before the TH introduction, OHCA patients were 
treated less aggressively, no institutional protocols ex-
isted, and treatment options were less advanced. In such 
circumstances, the majority of the most severe patients 
did not reach the cardiac ICU, while those who did were 
in less critical condition. In addition, after TH introduction 
in 2014, the patients with poor GCS on arrival underwent 
TH, while the patients with substantial neurological re-
covery did not. Consequently, the TH group consisted of 
more patients with a worse initial GCS score; intubation 
on arrival; mechanical ventilation treatment; the diagno-
sis of shock, pneumonia, and sepsis; vasopressor, inotrope, 
and antibiotic treatment; and renal replacement therapy. 
To eliminate these differences, we performed propensity 
score matching. Currently, the only indication to withhold 
TH in OHCA patients is a good GCS on admission, which 
is why it was included in the matching. Besides GCS, oth-
er variables included in the matching are all known to be 
associated with the outcome. The greatest concern was 
controlling for the time of treatment. As since 2014 all pa-
tients with OHCA have been treated with TH unless they 
had good neurological status (only a small proportion), we 
were unable to adequately adjust the groups for the time 
variable. Eventually, we included the time variable “since 
2010” in the matching process. This was chosen arbitrarily, 
as since 2010 no major infrastructural and staff change has 
occurred, and TH has been the most extensive treatment 
improvement. After matching, the majority of differences 
between TH and no TH group were balanced. The variables 
such as the use of analgosedation and mechanical venti-
lation, which are mandatory during TH, remained unbal-
anced. We were unable to prove that TH effect on survival 
was mediated by the year of admission. Several studies an-
alyzed OHCA populations before and after TH implemen-
tation, with similar time frames. Van der Wall et al (23) re-
ported no specific adjustment for the time of admission in 
a 10-year period. Sunde et al (24) compared patients treat-
ed and not treated with TH in two time periods (1996-1998 
vs 2003-2005) and reported as possible confounders the 
improvements in chain-of-survival but performed no strat-
ification by the time of treatment.
We found TH to be associated with better survival. Fur-
thermore, Cox proportional hazards model analysis re-
vealed TH as an independent predictor of survival. Similar 
results have been published earlier. Van der Wal et al (23) 
reported 20% relative risk reduction of intra-hospital mor-
tality in OHCA survivors after TH. The reported mortality 
rates were higher than in our study (van der Wal: before/
after TH 72.0%/65.4%; Pavlov: not treated/treated with 
TH 42.6%/39.7%). This can, at least partially, be as-
FiGuRe 3. Cox proportional hazards model survival curves 
separated by the use of therapeutic hypothermia.
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cribed to different protocols for OHCA patients (this study 
did not include OHCA patients without ROSC in ED; in the 
van der Wal study, all OHCA patients were directly admit-
ted to the ICU).
In our study, TH was not associated with better neuro-
logical outcome expressed as CPC score at discharge in 
Cox proportional hazards model. Such finding can be 
explained by sample size and residual between-group 
differences. As a surrogate marker for neurological im-
provement, we used the difference between the best 
and initial GCS score. In linear regression, TH was an in-
dependent predictor of greater difference (ie, better re-
covery). Our results, although from a small cohort, can 
be used in conjunction with results from larger studies 
demonstrating the benefit of TH in comatose OHCA sur-
vivors (23-27).
Several randomized studies raised doubts as to the exact 
role of TH in the outcomes of OHCA patients. Strategies 
such as early (intra-arrest) employment of TH (7-9), core 
temperature targeted to 33°C or 36°C (10), or management 
duration of 48 compared with 24 hours (11), led to no dif-
ference between the groups, while implementing TH for 
in-hospital cardiac arrest yielded even worse survival and 
neurological outcomes (12). Additionally, certain registry 
data also suggested a lack of a positive effect of TH. Mar-
tinell et al (13) failed to prove improved survival and neu-
rological outcome in 871 comatose OHCA survivors after 
adjustments for multiple confounders. The favorable treat-
ment consequences may be explained by the so called 
Hawthorne effect. It is a phenomenon of altered perfor-
mance (ie, over-performance) resulting from the aware-
ness of being observed, for example as a part of a study 
(28,29). Currently, Targeted Temperature Management 
study 2 (TTM2 study) is recruiting patients with random-
ization to cooling to 33°C or to avoiding hyperthermia only 
(maintaining core temperature <37.8°C) (30). The results of 
TTM2 study may elucidate the exact role of TH in the treat-
ment of OHCA patients.
The penetration of TH in Croatia is still low. The number of 
ICUs providing TH increased from 9% in 2008 (31) to 38.2% 
in 2017 (32). Yet, TH treatment is available to a greater pro-
portion of patients, as comatose OHCA survivors from ad-
ditional 29.4% of ICUs are urgently transferred through a 
primary PCI network to the ICUs providing TH (33). One 
quarter of patients treated with TH were transferred from 
two county hospitals, both around 55 km far from our 
Center.
This study has several limitations. Despite the effort in-
volved in case identification, low proportion of missing 
data, and statistical procedures such as matching and 
multivariable analyses, a retrospective design inevitably 
creates the limitations in terms of the number of avail-
able variables, certain level of selection bias, and inability 
to control the data acquisition quality. The fact that the 
study was performed at a single tertiary teaching center 
may limit the applicability of these results to institutions 
where different approaches and protocols for treatment 
of OHCA patients may exist. The time frame covered is 
substantially wide, raising the doubt about the effect of 
the available treatment options and protocols. Over time, 
recommendations for the treatment of OHCA patients, in-
cluding numerous complications observed in this study, 
have evolved. However, these changes would have af-
fected both groups of patients equally. Furthermore, we 
attempted to overcome this limitation by including the 
admission year in propensity score matching. Contem-
porary prognostication measures, such as neuron-specif-
ic enolase levels and somatosensory evoked potentials, 
were not available for the majority of patients not treated 
with TH. Regression and propensity score matching anal-
ysis were to some extent hindered by the sample size.
To conclude, this study showed that, after appropriate 
adjustments, TH was associated with better survival and 
certain variables suggesting an improved neurological 
outcome. According to these results and our opinion, TH 
continues to be a critical part of treatment of comatose 
OHCA survivors. TH implementation changed the focus of 
intensive care societies toward further improvements in re-
suscitation and post-arrest care. However, despite numer-
ous both positive and negative results, the exact role of TH 
in such patients’ outcomes is yet to be determined.
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